Transcriptomics and the mechanisms of antidepressant efficacy / Karen Hodgson en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No.1 (Enero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No.1 (Enero) . - pp. 105-112 Título : Transcriptomics and the mechanisms of antidepressant efficacy Tipo de documento: texto impreso Autores: Karen Hodgson, Autor ; Katherine E. Tansey, Autor ; Timothy R. Powell, Autor Fecha de publicación: 2021 Artículo en la página: pp. 105-112 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Expresion genica, Transcriptómica, Farmacogenética, Antidepresivos, Genética, Trastorno depresivo mayor Resumen: The mechanisms by which antidepressants have their effects are not clear and the reasons for variability in treatment outcomes are also unknown. However, there is evidence from candidate gene research that indicates gene expression changes may be involved in antidepressant action. Link: ./index.php?lvl=notice_display&id=26631 [artículo] Transcriptomics and the mechanisms of antidepressant efficacy [texto impreso] / Karen Hodgson, Autor ; Katherine E. Tansey, Autor ; Timothy R. Powell, Autor . - 2021 . - pp. 105-112. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No.1 (Enero) . - pp. 105-112 Palabras clave: Expresion genica, Transcriptómica, Farmacogenética, Antidepresivos, Genética, Trastorno depresivo mayor Resumen: The mechanisms by which antidepressants have their effects are not clear and the reasons for variability in treatment outcomes are also unknown. However, there is evidence from candidate gene research that indicates gene expression changes may be involved in antidepressant action. Link: ./index.php?lvl=notice_display&id=26631

---

1 (1 - 1 / 1)